8-K: Kewaunee Scientific Reports Strong Q1 FY26 Results

Kewaunee Scientific Corporation announced significant sales and earnings growth for its first quarter of fiscal year 2026, driven by the Nu Aire acquisition and improved productivity.

Summary

• Sales for the first quarter of fiscal year 2026 were $71,104,000, an increase of 46.9% compared to $48,393,000 in the prior year's first quarter.
• Pre-tax earnings for the quarter were $3,920,000, up 61.3% from $2,430,000 in the prior year quarter.
• Net earnings reached $3,093,000, compared to $2,193,000 for the prior year quarter.
• EBITDA for the quarter was $6,320,000, significantly up from $3,325,000 in the prior year quarter.
• Diluted earnings per share were $1.04, compared to $0.74 in the prior year quarter.
• The company's order backlog stood at $205.0 million on July 31, 2025, compared to $159.4 million on July 31, 2024, and $214.6 million on April 30, 2025.
• Domestic segment sales increased by 53.0% to $54,352,000, driven by the incorporation of Nu Aire's results, steady manufacturing volumes, improved productivity, and cost management.
• International segment sales increased by 30.2% to $16,752,000, benefiting from decreasing customer site delays.
• Corporate segment pre-tax net loss was $3,058,000, compared to a loss of $1,992,000 in the prior year quarter, due to strategic investments in its Corporate platform and increased compliance costs.
• Total cash on hand was $20,441,000 on July 31, 2025, up from $17,164,000 on April 30, 2025.
• Working capital was $66,662,000 on July 31, 2025, an increase from $64,651,000 on April 30, 2025.
• The debt-to-equity ratio improved to 0.94-to-1 on July 31, 2025, from 0.99-to-1 on April 30, 2025.

Sentiment

Score: 7

Explanation: The company reported strong financial performance for Q1 FY26, with significant growth in sales, earnings, and EBITDA, partly driven by the Nu Aire acquisition. However, management's forward-looking statements indicate anticipated uneven quarterly performance due to project delivery volatility and near-term pressure on earnings from strategic investments, tempering the overall positive sentiment.

Positives

• Achieved substantial sales growth of 46.9% year-over-year, demonstrating strong market demand and successful integration of Nu Aire.
• Reported significant pre-tax earnings growth of 61.3% and net earnings growth of 41% year-over-year.
• EBITDA nearly doubled to $6,320,000, indicating improved operational efficiency and profitability.
• Diluted earnings per share increased by 40.5% to $1.04.
• Order backlog remains near historically high levels at $205.0 million, providing future revenue visibility.
• Domestic segment showed robust performance with 53.0% sales growth, attributed to the Nu Aire acquisition, stable manufacturing, and cost management.
• International segment sales grew by 30.2%, benefiting from a reduction in prior customer site delays.
• Increased cash on hand to $20,441,000 and working capital to $66,662,000, strengthening liquidity.
• Improved debt-to-equity ratio to 0.94-to-1, reflecting a healthier balance sheet.
• Management anticipates delivering better unadjusted EBITDA in fiscal year 2026 compared to fiscal year 2025.

Negatives

• Corporate segment pre-tax net loss increased to $3,058,000 from $1,992,000 in the prior year, primarily due to strategic investments and increased compliance costs.
• Corporate segment EBITDA remained negative at ($2,311,000).
• Order backlog decreased slightly from $214.6 million on April 30, 2025, to $205.0 million on July 31, 2025.
• Management expects volatility in project delivery timelines, which will likely cause uneven quarterly performance for the balance of fiscal year 2026, potentially starting in the second quarter.
• Strategic investments in the Corporate platform are expected to place pressure on earnings growth in the near term.

Risks

• Challenging market conditions due to uncertain government policy, evolving tariff structures, and broader geopolitical upheaval.
• Volatility in project delivery timelines, which may lead to uneven quarterly performance.
• Dependence on customers' required delivery schedules.
• Fluctuations in the company's operating results from quarter to quarter.
• Risks associated with international operations, including foreign currency fluctuations.
• Changes in the legal and regulatory environment.
• Changes in raw materials and commodity costs.
• Potential impacts from acts of terrorism, war, governmental action, natural disasters, and other Force Majeure events.
• Ability to fully realize the anticipated benefits from the Nu Aire acquisition.
• Competitive and general economic conditions, including disruptions from government mandates, supplier constraints, and other supply disruptions.
• Technological changes in operations or the industry.

Future Outlook

Management anticipates volatility in project delivery timelines, which is expected to cause uneven performance by quarter for the balance of fiscal year 2026, likely starting in the second quarter. Strategic investments in the Corporate platform are projected to place pressure on earnings growth in the near term. Despite these challenges, the company expects to deliver better unadjusted EBITDA in fiscal year 2026 than in fiscal year 2025, confident that current strategies and investments will position Kewaunee for rapid and sustained long-term growth.

Management Comments

• "Our Domestic and International segments delivered solid financial performance in the first quarter despite challenging market conditions as a result of uncertain government policy, evolving tariff structures and broader geopolitical upheaval."
• "While our overall backlog remains near historically high levels, we are experiencing volatility in project delivery timelines that we expect will cause uneven performance by quarter for the balance of fiscal year 2026, likely starting in the second quarter. This is a reality of both the uncertainty in the market, and the nature of construction-related manufacturing, where project timing often shifts, causing peaks and valleys in production schedules."
• "Kewaunee is focused on growth, both organically and inorganically, and is committed to making strategic investments in the people, processes, and technology that will support and enable this growth in a sustainable manner."
• "Though this will place pressure on earnings growth in the near term, we believe it will position Kewaunee for rapid and sustained growth in the future, allowing us to gain leverage on these investments over the long term."
• "Despite our anticipation of uneven quarterly performance for the remainder of fiscal year 2026, and increasing strategic investment in the Corporate platform, we expect to deliver better unadjusted EBITDA in fiscal year 2026 than we did in fiscal year 2025. We are confident in the strategies we are employing and the long-term health of the business."

Industry Context

Kewaunee Scientific operates in the specialized market of laboratory, healthcare, and technical furniture, which is often tied to large-scale research, healthcare, and educational infrastructure projects. The acquisition of Nu Aire expands its product offerings into biological safety cabinets and other essential laboratory products, aligning with the growing demand in life sciences and research sectors. The company's mention of 'uncertain government policy, evolving tariff structures and broader geopolitical upheaval' reflects the broader macroeconomic and geopolitical challenges impacting global supply chains and project timelines, which are common concerns for companies with significant international operations and reliance on large capital projects.

Corporate Governance

Stakeholder Impact

• Shareholders: Strong Q1 financial performance and long-term growth strategy are positive, but anticipated near-term earnings pressure and uneven quarterly results may introduce volatility.
• Employees: Strategic investments in people, processes, and technology suggest potential for growth and development opportunities within the company.
• Customers: Decreasing international customer site delays and improved productivity in the Domestic segment could lead to more reliable deliveries, though overall project delivery volatility might still impact some timelines.
• Creditors: Improved debt-to-equity ratio and increased cash on hand indicate a stronger financial position, potentially reducing credit risk.

Next Steps

• Continue strategic investments in people, processes, and technology to support future growth.
• Manage through anticipated uneven quarterly performance for the remainder of fiscal year 2026.
• Focus on both organic and inorganic growth initiatives.
• Address increased compliance costs related to the anticipated triggering of Sarbanes-Oxley 404(b) requirements.

Key Dates

Recommendation

Kewaunee Scientific delivered robust first-quarter results, significantly increasing sales, earnings, and EBITDA, partly due to the Nu Aire acquisition. The backlog remains strong, and debt metrics improved. However, management explicitly warns of anticipated uneven quarterly performance for the remainder of fiscal year 2026 due to project delivery volatility and notes that strategic investments will pressure near-term earnings. While the long-term outlook is positive, the near-term uncertainty and investment costs suggest a 'hold' position until there is clearer visibility on the consistency of future performance and the impact of these strategic initiatives.

Keywords

Kewaunee Scientific, KEQU, laboratory furniture, healthcare furniture, technical furniture, Nu Aire, Q1 earnings, fiscal year 2026, financial results, lab equipment, EBITDA, backlog